Peptide-based urinary monitoring of fibrotic nonalcoholic steatohepatitis by mass-barcoded activity-based sensors
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Peptide-based urinary monitoring of fibrotic nonalcoholic steatohepatitis by mass-barcoded activity-based sensors
Authors
Keywords
-
Journal
Science Translational Medicine
Volume 13, Issue 616, Pages -
Publisher
American Association for the Advancement of Science (AAAS)
Online
2021-10-22
DOI
10.1126/scitranslmed.abe8939
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cilofexor, a Nonsteroidal FXR Agonist, in Non‐Cirrhotic Patients with Nonalcoholic Steatohepatitis: A Phase 2 Randomized Controlled Trial
- (2020) Keyur Patel et al. HEPATOLOGY
- NAFLD as a driver of chronic kidney disease
- (2020) Christopher D. Byrne et al. JOURNAL OF HEPATOLOGY
- Urinary detection of lung cancer in mice via noninvasive pulmonary protease profiling
- (2020) Jesse D. Kirkpatrick et al. Science Translational Medicine
- Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis
- (2020) Olivier Govaere et al. Science Translational Medicine
- Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
- (2019) Peter J. Eddowes et al. GASTROENTEROLOGY
- Non-invasive early detection of acute transplant rejection via nanosensors of granzyme B activity
- (2019) Quoc D. Mac et al. Nature Biomedical Engineering
- From NASH to HCC: current concepts and future challenges
- (2019) Quentin M. Anstee et al. Nature Reviews Gastroenterology & Hepatology
- GS-0976 (Firsocostat): an investigational liver-directed acetyl-CoA carboxylase (ACC) inhibitor for the treatment of non-alcoholic steatohepatitis (NASH)
- (2019) Naim Alkhouri et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Current Status in Testing for Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH)
- (2019) Hannah K. Drescher et al. Cells
- Obesity-linked suppression of membrane-bound O-acyltransferase 7 (MBOAT7) drives non-alcoholic fatty liver disease
- (2019) Robert N Helsley et al. eLife
- Rates and Factors Associated With Placebo Response in Trials of Pharmacotherapies for Nonalcoholic Steatohepatitis: Systematic Review and Meta-analysis
- (2018) Ma Ai Thanda Han et al. Clinical Gastroenterology and Hepatology
- Optimal threshold of controlled attenuation parameter with MRI-PDFF as the gold standard for the detection of hepatic steatosis
- (2018) Cyrielle Caussy et al. HEPATOLOGY
- Case definitions for inclusion and analysis of endpoints in clinical trials for nonalcoholic steatohepatitis through the lens of regulatory science
- (2018) Mohammad Shadab Siddiqui et al. HEPATOLOGY
- Combination of an FXR agonist and an ACC inhibitor increases anti-fibrotic efficacy in rodent models of NASH
- (2018) J. Bates et al. JOURNAL OF HEPATOLOGY
- Non-invasive assessment of non-alcoholic fatty liver disease: Clinical prediction rules and blood-based biomarkers
- (2018) Eduardo Vilar-Gomez et al. JOURNAL OF HEPATOLOGY
- Matrix metalloproteinases and liver fibrosis (translational aspects)
- (2018) Elke Roeb MATRIX BIOLOGY
- Quantitative Elastography Methods in Liver Disease: Current Evidence and Future Directions
- (2018) Paul Kennedy et al. RADIOLOGY
- Classification of prostate cancer using a protease activity nanosensor library
- (2018) Jaideep S. Dudani et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: A randomized, phase 2 trial
- (2017) Rohit Loomba et al. HEPATOLOGY
- Proteases Revisited: Roles and Therapeutic Implications in Fibrosis
- (2017) Jakub Kryczka et al. MEDIATORS OF INFLAMMATION
- Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
- (2017) Zobair Younossi et al. Nature Reviews Gastroenterology & Hepatology
- Human hepatic gene expression signature of non-alcoholic fatty liver disease progression, a meta-analysis
- (2017) Maria Ryaboshapkina et al. Scientific Reports
- Cathepsin D regulates lipid metabolism in murine steatohepatitis
- (2017) Tom Houben et al. Scientific Reports
- Histology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in Adults and Children
- (2016) David E. Kleiner et al. Clinics in Liver Disease
- A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer
- (2016) Amon Asgharpour et al. JOURNAL OF HEPATOLOGY
- Activation of Proteinase 3 Contributes to Nonalcoholic Fatty Liver Disease and Insulin Resistance
- (2016) Erik JM Toonen et al. MOLECULAR MEDICINE
- Fibroblast activation protein (FAP) as a novel metabolic target
- (2016) Miguel Angel Sánchez-Garrido et al. Molecular Metabolism
- Multiplex Serum Protein Analysis Identifies Novel Biomarkers of Advanced Fibrosis in Patients with Chronic Liver Disease with the Potential to Improve Diagnostic Accuracy of Established Biomarkers
- (2016) Katharine M. Irvine et al. PLoS One
- Plasma cathepsin D correlates with histological classifications of fatty liver disease in adults and responds to intervention
- (2016) Sofie M. A. Walenbergh et al. Scientific Reports
- Evaluating Robustness and Sensitivity of the NanoString Technologies nCounter Platform to Enable Multiplexed Gene Expression Analysis of Clinical Samples
- (2015) M. H. Veldman-Jones et al. CANCER RESEARCH
- Fibrosis Progression in Nonalcoholic Fatty Liver vs Nonalcoholic Steatohepatitis: A Systematic Review and Meta-analysis of Paired-Biopsy Studies
- (2015) Siddharth Singh et al. Clinical Gastroenterology and Hepatology
- What is the future of PEGylated therapies?
- (2015) Magdalena Swierczewska et al. EXPERT OPINION ON EMERGING DRUGS
- Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
- (2015) Paul Angulo et al. GASTROENTEROLOGY
- Mathematical framework for activity-based cancer biomarkers
- (2015) Gabriel A. Kwong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Practice patterns in NAFLD and NASH: real life differs from published guidelines
- (2015) Mary E. Rinella et al. Therapeutic Advances in Gastroenterology
- Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease
- (2014) Pierre Bedossa et al. HEPATOLOGY
- The serine protease prostasin regulates hepatic insulin sensitivity by modulating TLR4 signalling
- (2014) Kohei Uchimura et al. Nature Communications
- An improved mouse model that rapidly develops fibrosis in non-alcoholic steatohepatitis
- (2013) Masahiko Matsumoto et al. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
- Suppressed mitochondrial biogenesis in folic acid-induced acute kidney injury and early fibrosis
- (2013) L. Jay Stallons et al. TOXICOLOGY LETTERS
- Higher hepatic gene expression and serum levels of matrix metalloproteinase-2 are associated with steatohepatitis in non-alcoholic fatty liver diseases
- (2012) Hidenori Toyoda et al. BIOMARKERS
- Mass-encoded synthetic biomarkers for multiplexed urinary monitoring of disease
- (2012) Gabriel A Kwong et al. NATURE BIOTECHNOLOGY
- Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings
- (2010) Elizabeth M. Brunt et al. HEPATOLOGY
- BTBR Ob/Ob Mutant Mice Model Progressive Diabetic Nephropathy
- (2010) K. L. Hudkins et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Liver immunolocalization and plasma levels of MMP-9 in non-alcoholic steatohepatitis (NASH) and hepatitis C infection
- (2009) Fabio D’Amico et al. ACTA HISTOCHEMICA
- Comparison of Noninvasive Markers of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
- (2009) Amy G. Shah et al. Clinical Gastroenterology and Hepatology
- Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: A multicenter validation study
- (2009) Ariel E. Feldstein et al. HEPATOLOGY
- Cathepsins B and D drive hepatic stellate cell proliferation and promote their fibrogenic potential
- (2008) Anna Moles et al. HEPATOLOGY
- Liver biopsy: The best, not the gold standard
- (2008) Pierre Bedossa et al. JOURNAL OF HEPATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started